nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—PTGS1—Etoposide—muscle cancer	0.115	0.16	CbGbCtD
Zolpidem—CYP1A2—Dacarbazine—muscle cancer	0.105	0.146	CbGbCtD
Zolpidem—CYP3A7—Vincristine—muscle cancer	0.1	0.139	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.1	0.139	CbGbCtD
Zolpidem—CYP3A5—Vincristine—muscle cancer	0.0751	0.105	CbGbCtD
Zolpidem—CYP3A5—Etoposide—muscle cancer	0.0688	0.0959	CbGbCtD
Zolpidem—CYP1A2—Etoposide—muscle cancer	0.0512	0.0713	CbGbCtD
Zolpidem—CYP3A4—Vincristine—muscle cancer	0.0293	0.0408	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—muscle cancer	0.0288	0.0401	CbGbCtD
Zolpidem—CYP3A4—Etoposide—muscle cancer	0.0268	0.0374	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—muscle cancer	0.0183	0.0255	CbGbCtD
Zolpidem—Tolmetin—PTGS2—muscle cancer	0.00484	1	CrCbGaD
Zolpidem—Purpura—Doxorubicin—muscle cancer	0.000529	0.00191	CcSEcCtD
Zolpidem—Abdominal pain—Dactinomycin—muscle cancer	0.000528	0.00191	CcSEcCtD
Zolpidem—Body temperature increased—Dactinomycin—muscle cancer	0.000528	0.00191	CcSEcCtD
Zolpidem—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000527	0.0019	CcSEcCtD
Zolpidem—Loss of consciousness—Etoposide—muscle cancer	0.000521	0.00188	CcSEcCtD
Zolpidem—Lethargy—Doxorubicin—muscle cancer	0.000521	0.00188	CcSEcCtD
Zolpidem—Decreased appetite—Vincristine—muscle cancer	0.000519	0.00187	CcSEcCtD
Zolpidem—Cough—Etoposide—muscle cancer	0.000517	0.00187	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Vincristine—muscle cancer	0.000515	0.00186	CcSEcCtD
Zolpidem—Fatigue—Vincristine—muscle cancer	0.000515	0.00186	CcSEcCtD
Zolpidem—Hypertension—Etoposide—muscle cancer	0.000512	0.00185	CcSEcCtD
Zolpidem—Constipation—Vincristine—muscle cancer	0.00051	0.00184	CcSEcCtD
Zolpidem—Pain—Vincristine—muscle cancer	0.00051	0.00184	CcSEcCtD
Zolpidem—Diplopia—Doxorubicin—muscle cancer	0.00051	0.00184	CcSEcCtD
Zolpidem—Osteoarthritis—Doxorubicin—muscle cancer	0.00051	0.00184	CcSEcCtD
Zolpidem—Chest pain—Etoposide—muscle cancer	0.000504	0.00182	CcSEcCtD
Zolpidem—Migraine—Doxorubicin—muscle cancer	0.000502	0.00181	CcSEcCtD
Zolpidem—Affect lability—Doxorubicin—muscle cancer	0.000502	0.00181	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000501	0.00181	CcSEcCtD
Zolpidem—Discomfort—Etoposide—muscle cancer	0.000498	0.0018	CcSEcCtD
Zolpidem—Face oedema—Doxorubicin—muscle cancer	0.000493	0.00178	CcSEcCtD
Zolpidem—Hypersensitivity—Dactinomycin—muscle cancer	0.000492	0.00178	CcSEcCtD
Zolpidem—Abdominal discomfort—Methotrexate—muscle cancer	0.000488	0.00176	CcSEcCtD
Zolpidem—Gastrointestinal pain—Vincristine—muscle cancer	0.000488	0.00176	CcSEcCtD
Zolpidem—Confusional state—Etoposide—muscle cancer	0.000488	0.00176	CcSEcCtD
Zolpidem—Anaphylactic shock—Etoposide—muscle cancer	0.000484	0.00175	CcSEcCtD
Zolpidem—Mood swings—Doxorubicin—muscle cancer	0.000483	0.00175	CcSEcCtD
Zolpidem—Infection—Etoposide—muscle cancer	0.00048	0.00173	CcSEcCtD
Zolpidem—Ataxia—Doxorubicin—muscle cancer	0.00048	0.00173	CcSEcCtD
Zolpidem—Asthenia—Dactinomycin—muscle cancer	0.000479	0.00173	CcSEcCtD
Zolpidem—Dysuria—Methotrexate—muscle cancer	0.000476	0.00172	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000473	0.00171	CcSEcCtD
Zolpidem—Tachycardia—Etoposide—muscle cancer	0.000472	0.0017	CcSEcCtD
Zolpidem—Abdominal pain—Vincristine—muscle cancer	0.000472	0.0017	CcSEcCtD
Zolpidem—Body temperature increased—Vincristine—muscle cancer	0.000472	0.0017	CcSEcCtD
Zolpidem—Skin disorder—Etoposide—muscle cancer	0.00047	0.0017	CcSEcCtD
Zolpidem—Erectile dysfunction—Methotrexate—muscle cancer	0.000469	0.00169	CcSEcCtD
Zolpidem—Hyperhidrosis—Etoposide—muscle cancer	0.000467	0.00169	CcSEcCtD
Zolpidem—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000466	0.00168	CcSEcCtD
Zolpidem—Photosensitivity reaction—Methotrexate—muscle cancer	0.000465	0.00168	CcSEcCtD
Zolpidem—Breast disorder—Doxorubicin—muscle cancer	0.000461	0.00166	CcSEcCtD
Zolpidem—Anorexia—Etoposide—muscle cancer	0.000461	0.00166	CcSEcCtD
Zolpidem—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00046	0.00166	CcSEcCtD
Zolpidem—Diarrhoea—Dactinomycin—muscle cancer	0.000457	0.00165	CcSEcCtD
Zolpidem—Pneumonia—Methotrexate—muscle cancer	0.000457	0.00165	CcSEcCtD
Zolpidem—Nasopharyngitis—Doxorubicin—muscle cancer	0.000456	0.00165	CcSEcCtD
Zolpidem—Infestation NOS—Methotrexate—muscle cancer	0.000454	0.00164	CcSEcCtD
Zolpidem—Drowsiness—Methotrexate—muscle cancer	0.000454	0.00164	CcSEcCtD
Zolpidem—Infestation—Methotrexate—muscle cancer	0.000454	0.00164	CcSEcCtD
Zolpidem—Depression—Methotrexate—muscle cancer	0.000453	0.00163	CcSEcCtD
Zolpidem—Hypotension—Etoposide—muscle cancer	0.000452	0.00163	CcSEcCtD
Zolpidem—Gastritis—Doxorubicin—muscle cancer	0.000452	0.00163	CcSEcCtD
Zolpidem—Muscular weakness—Doxorubicin—muscle cancer	0.00045	0.00162	CcSEcCtD
Zolpidem—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00045	0.00162	CcSEcCtD
Zolpidem—Stomatitis—Methotrexate—muscle cancer	0.000443	0.0016	CcSEcCtD
Zolpidem—Conjunctivitis—Methotrexate—muscle cancer	0.000441	0.00159	CcSEcCtD
Zolpidem—Influenza—Doxorubicin—muscle cancer	0.000441	0.00159	CcSEcCtD
Zolpidem—Dysphagia—Doxorubicin—muscle cancer	0.000441	0.00159	CcSEcCtD
Zolpidem—Hypersensitivity—Vincristine—muscle cancer	0.00044	0.00159	CcSEcCtD
Zolpidem—Paraesthesia—Etoposide—muscle cancer	0.000434	0.00157	CcSEcCtD
Zolpidem—Dyspnoea—Etoposide—muscle cancer	0.000431	0.00156	CcSEcCtD
Zolpidem—Somnolence—Etoposide—muscle cancer	0.00043	0.00155	CcSEcCtD
Zolpidem—Angina pectoris—Doxorubicin—muscle cancer	0.00043	0.00155	CcSEcCtD
Zolpidem—Epistaxis—Methotrexate—muscle cancer	0.000428	0.00155	CcSEcCtD
Zolpidem—Asthenia—Vincristine—muscle cancer	0.000428	0.00155	CcSEcCtD
Zolpidem—Vomiting—Dactinomycin—muscle cancer	0.000425	0.00153	CcSEcCtD
Zolpidem—Bronchitis—Doxorubicin—muscle cancer	0.000424	0.00153	CcSEcCtD
Zolpidem—Rash—Dactinomycin—muscle cancer	0.000421	0.00152	CcSEcCtD
Zolpidem—Decreased appetite—Etoposide—muscle cancer	0.00042	0.00152	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Etoposide—muscle cancer	0.000417	0.00151	CcSEcCtD
Zolpidem—Fatigue—Etoposide—muscle cancer	0.000417	0.00151	CcSEcCtD
Zolpidem—Constipation—Etoposide—muscle cancer	0.000414	0.00149	CcSEcCtD
Zolpidem—Pain—Etoposide—muscle cancer	0.000414	0.00149	CcSEcCtD
Zolpidem—Dysuria—Doxorubicin—muscle cancer	0.000412	0.00149	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00041	0.00148	CcSEcCtD
Zolpidem—Diarrhoea—Vincristine—muscle cancer	0.000408	0.00147	CcSEcCtD
Zolpidem—Pollakiuria—Doxorubicin—muscle cancer	0.000407	0.00147	CcSEcCtD
Zolpidem—Pharyngitis—Methotrexate—muscle cancer	0.000405	0.00146	CcSEcCtD
Zolpidem—Urinary tract disorder—Methotrexate—muscle cancer	0.000403	0.00145	CcSEcCtD
Zolpidem—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000403	0.00145	CcSEcCtD
Zolpidem—Urethral disorder—Methotrexate—muscle cancer	0.0004	0.00144	CcSEcCtD
Zolpidem—Weight decreased—Doxorubicin—muscle cancer	0.000399	0.00144	CcSEcCtD
Zolpidem—Feeling abnormal—Etoposide—muscle cancer	0.000399	0.00144	CcSEcCtD
Zolpidem—Hyperglycaemia—Doxorubicin—muscle cancer	0.000398	0.00144	CcSEcCtD
Zolpidem—Nausea—Dactinomycin—muscle cancer	0.000397	0.00143	CcSEcCtD
Zolpidem—Pneumonia—Doxorubicin—muscle cancer	0.000396	0.00143	CcSEcCtD
Zolpidem—Gastrointestinal pain—Etoposide—muscle cancer	0.000395	0.00143	CcSEcCtD
Zolpidem—Dizziness—Vincristine—muscle cancer	0.000395	0.00143	CcSEcCtD
Zolpidem—Infestation NOS—Doxorubicin—muscle cancer	0.000393	0.00142	CcSEcCtD
Zolpidem—Infestation—Doxorubicin—muscle cancer	0.000393	0.00142	CcSEcCtD
Zolpidem—Drowsiness—Doxorubicin—muscle cancer	0.000393	0.00142	CcSEcCtD
Zolpidem—Visual impairment—Methotrexate—muscle cancer	0.000393	0.00142	CcSEcCtD
Zolpidem—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000385	0.00139	CcSEcCtD
Zolpidem—Urticaria—Etoposide—muscle cancer	0.000384	0.00139	CcSEcCtD
Zolpidem—Stomatitis—Doxorubicin—muscle cancer	0.000383	0.00138	CcSEcCtD
Zolpidem—Body temperature increased—Etoposide—muscle cancer	0.000382	0.00138	CcSEcCtD
Zolpidem—Abdominal pain—Etoposide—muscle cancer	0.000382	0.00138	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—muscle cancer	0.000382	0.00138	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—muscle cancer	0.000382	0.00138	CcSEcCtD
Zolpidem—Eye disorder—Methotrexate—muscle cancer	0.000381	0.00138	CcSEcCtD
Zolpidem—Tinnitus—Methotrexate—muscle cancer	0.00038	0.00137	CcSEcCtD
Zolpidem—Vomiting—Vincristine—muscle cancer	0.00038	0.00137	CcSEcCtD
Zolpidem—Cardiac disorder—Methotrexate—muscle cancer	0.000378	0.00137	CcSEcCtD
Zolpidem—Rash—Vincristine—muscle cancer	0.000376	0.00136	CcSEcCtD
Zolpidem—Dermatitis—Vincristine—muscle cancer	0.000376	0.00136	CcSEcCtD
Zolpidem—Headache—Vincristine—muscle cancer	0.000374	0.00135	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—muscle cancer	0.000371	0.00134	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—muscle cancer	0.000369	0.00133	CcSEcCtD
Zolpidem—Mediastinal disorder—Methotrexate—muscle cancer	0.000367	0.00133	CcSEcCtD
Zolpidem—Chills—Methotrexate—muscle cancer	0.000366	0.00132	CcSEcCtD
Zolpidem—Mental disorder—Methotrexate—muscle cancer	0.000357	0.00129	CcSEcCtD
Zolpidem—Hypersensitivity—Etoposide—muscle cancer	0.000356	0.00129	CcSEcCtD
Zolpidem—Erythema—Methotrexate—muscle cancer	0.000355	0.00128	CcSEcCtD
Zolpidem—Malnutrition—Methotrexate—muscle cancer	0.000355	0.00128	CcSEcCtD
Zolpidem—Nausea—Vincristine—muscle cancer	0.000355	0.00128	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—muscle cancer	0.000354	0.00128	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—muscle cancer	0.000351	0.00127	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—muscle cancer	0.00035	0.00126	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—muscle cancer	0.000349	0.00126	CcSEcCtD
Zolpidem—Dysgeusia—Methotrexate—muscle cancer	0.000348	0.00125	CcSEcCtD
Zolpidem—Asthenia—Etoposide—muscle cancer	0.000347	0.00125	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—muscle cancer	0.000347	0.00125	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—muscle cancer	0.000346	0.00125	CcSEcCtD
Zolpidem—Back pain—Methotrexate—muscle cancer	0.000343	0.00124	CcSEcCtD
Zolpidem—Pruritus—Etoposide—muscle cancer	0.000342	0.00124	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—muscle cancer	0.00034	0.00123	CcSEcCtD
Zolpidem—Vision blurred—Methotrexate—muscle cancer	0.000334	0.00121	CcSEcCtD
Zolpidem—Diarrhoea—Etoposide—muscle cancer	0.000331	0.00119	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—muscle cancer	0.00033	0.00119	CcSEcCtD
Zolpidem—Ill-defined disorder—Methotrexate—muscle cancer	0.000329	0.00119	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—muscle cancer	0.000329	0.00119	CcSEcCtD
Zolpidem—Anaemia—Methotrexate—muscle cancer	0.000328	0.00118	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—muscle cancer	0.000328	0.00118	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—muscle cancer	0.000328	0.00118	CcSEcCtD
Zolpidem—Malaise—Methotrexate—muscle cancer	0.00032	0.00116	CcSEcCtD
Zolpidem—Dizziness—Etoposide—muscle cancer	0.00032	0.00115	CcSEcCtD
Zolpidem—Vertigo—Methotrexate—muscle cancer	0.000319	0.00115	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—muscle cancer	0.000318	0.00115	CcSEcCtD
Zolpidem—Leukopenia—Methotrexate—muscle cancer	0.000318	0.00115	CcSEcCtD
Zolpidem—Chills—Doxorubicin—muscle cancer	0.000317	0.00114	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—muscle cancer	0.000315	0.00114	CcSEcCtD
Zolpidem—Cough—Methotrexate—muscle cancer	0.00031	0.00112	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—muscle cancer	0.000309	0.00112	CcSEcCtD
Zolpidem—Vomiting—Etoposide—muscle cancer	0.000307	0.00111	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—muscle cancer	0.000307	0.00111	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—muscle cancer	0.000307	0.00111	CcSEcCtD
Zolpidem—Rash—Etoposide—muscle cancer	0.000305	0.0011	CcSEcCtD
Zolpidem—Dermatitis—Etoposide—muscle cancer	0.000305	0.0011	CcSEcCtD
Zolpidem—Headache—Etoposide—muscle cancer	0.000303	0.00109	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—muscle cancer	0.000303	0.00109	CcSEcCtD
Zolpidem—Myalgia—Methotrexate—muscle cancer	0.000302	0.00109	CcSEcCtD
Zolpidem—Arthralgia—Methotrexate—muscle cancer	0.000302	0.00109	CcSEcCtD
Zolpidem—Chest pain—Methotrexate—muscle cancer	0.000302	0.00109	CcSEcCtD
Zolpidem—Tension—Doxorubicin—muscle cancer	0.000302	0.00109	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—muscle cancer	0.000301	0.00109	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0003	0.00108	CcSEcCtD
Zolpidem—Discomfort—Methotrexate—muscle cancer	0.000299	0.00108	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—muscle cancer	0.000298	0.00108	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—muscle cancer	0.000297	0.00107	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—muscle cancer	0.000295	0.00107	CcSEcCtD
Zolpidem—Confusional state—Methotrexate—muscle cancer	0.000292	0.00105	CcSEcCtD
Zolpidem—Anaphylactic shock—Methotrexate—muscle cancer	0.00029	0.00105	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—muscle cancer	0.00029	0.00105	CcSEcCtD
Zolpidem—Infection—Methotrexate—muscle cancer	0.000288	0.00104	CcSEcCtD
Zolpidem—Nausea—Etoposide—muscle cancer	0.000287	0.00104	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—muscle cancer	0.000285	0.00103	CcSEcCtD
Zolpidem—Nervous system disorder—Methotrexate—muscle cancer	0.000284	0.00103	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—muscle cancer	0.000284	0.00103	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—muscle cancer	0.000282	0.00102	CcSEcCtD
Zolpidem—Skin disorder—Methotrexate—muscle cancer	0.000281	0.00102	CcSEcCtD
Zolpidem—Hyperhidrosis—Methotrexate—muscle cancer	0.00028	0.00101	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—muscle cancer	0.000277	0.001	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—muscle cancer	0.000276	0.000997	CcSEcCtD
Zolpidem—Anorexia—Methotrexate—muscle cancer	0.000276	0.000997	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—muscle cancer	0.000276	0.000995	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—muscle cancer	0.000275	0.000993	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—muscle cancer	0.000272	0.00098	CcSEcCtD
Zolpidem—Hypotension—Methotrexate—muscle cancer	0.000271	0.000977	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—muscle cancer	0.00027	0.000975	CcSEcCtD
Zolpidem—Cough—Doxorubicin—muscle cancer	0.000268	0.000968	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—muscle cancer	0.000265	0.000958	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000264	0.000953	CcSEcCtD
Zolpidem—Insomnia—Methotrexate—muscle cancer	0.000262	0.000946	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—muscle cancer	0.000262	0.000945	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—muscle cancer	0.000262	0.000945	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—muscle cancer	0.000262	0.000945	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—muscle cancer	0.000261	0.000941	CcSEcCtD
Zolpidem—Paraesthesia—Methotrexate—muscle cancer	0.00026	0.000939	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00026	0.000938	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—muscle cancer	0.000259	0.000933	CcSEcCtD
Zolpidem—Dyspnoea—Methotrexate—muscle cancer	0.000258	0.000932	CcSEcCtD
Zolpidem—Somnolence—Methotrexate—muscle cancer	0.000258	0.00093	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—muscle cancer	0.000256	0.000924	CcSEcCtD
Zolpidem—Dyspepsia—Methotrexate—muscle cancer	0.000255	0.00092	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—muscle cancer	0.000253	0.000913	CcSEcCtD
Zolpidem—Decreased appetite—Methotrexate—muscle cancer	0.000252	0.000909	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—muscle cancer	0.000251	0.000905	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—muscle cancer	0.000251	0.000905	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00025	0.000903	CcSEcCtD
Zolpidem—Fatigue—Methotrexate—muscle cancer	0.00025	0.000902	CcSEcCtD
Zolpidem—Infection—Doxorubicin—muscle cancer	0.000249	0.0009	CcSEcCtD
Zolpidem—Pain—Methotrexate—muscle cancer	0.000248	0.000894	CcSEcCtD
Zolpidem—Shock—Doxorubicin—muscle cancer	0.000247	0.000891	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—muscle cancer	0.000246	0.000888	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—muscle cancer	0.000245	0.000884	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—muscle cancer	0.000244	0.000879	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—muscle cancer	0.000242	0.000875	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—muscle cancer	0.000239	0.000863	CcSEcCtD
Zolpidem—Feeling abnormal—Methotrexate—muscle cancer	0.000239	0.000862	CcSEcCtD
Zolpidem—Gastrointestinal pain—Methotrexate—muscle cancer	0.000237	0.000855	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—muscle cancer	0.000234	0.000846	CcSEcCtD
Zolpidem—Urticaria—Methotrexate—muscle cancer	0.00023	0.000831	CcSEcCtD
Zolpidem—Abdominal pain—Methotrexate—muscle cancer	0.000229	0.000827	CcSEcCtD
Zolpidem—Body temperature increased—Methotrexate—muscle cancer	0.000229	0.000827	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000229	0.000825	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—muscle cancer	0.000227	0.000819	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—muscle cancer	0.000225	0.000813	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—muscle cancer	0.000224	0.000807	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—muscle cancer	0.000223	0.000805	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—muscle cancer	0.000221	0.000797	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—muscle cancer	0.000218	0.000787	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000217	0.000782	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—muscle cancer	0.000216	0.000781	CcSEcCtD
Zolpidem—Pain—Doxorubicin—muscle cancer	0.000214	0.000774	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—muscle cancer	0.000214	0.000774	CcSEcCtD
Zolpidem—Hypersensitivity—Methotrexate—muscle cancer	0.000213	0.00077	CcSEcCtD
Zolpidem—Asthenia—Methotrexate—muscle cancer	0.000208	0.00075	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—muscle cancer	0.000207	0.000746	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000205	0.00074	CcSEcCtD
Zolpidem—Pruritus—Methotrexate—muscle cancer	0.000205	0.00074	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—muscle cancer	0.000199	0.000719	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—muscle cancer	0.000198	0.000716	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—muscle cancer	0.000198	0.000716	CcSEcCtD
Zolpidem—Diarrhoea—Methotrexate—muscle cancer	0.000198	0.000715	CcSEcCtD
Zolpidem—Dizziness—Methotrexate—muscle cancer	0.000192	0.000691	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—muscle cancer	0.000185	0.000667	CcSEcCtD
Zolpidem—Vomiting—Methotrexate—muscle cancer	0.000184	0.000665	CcSEcCtD
Zolpidem—Rash—Methotrexate—muscle cancer	0.000183	0.000659	CcSEcCtD
Zolpidem—Dermatitis—Methotrexate—muscle cancer	0.000182	0.000659	CcSEcCtD
Zolpidem—Headache—Methotrexate—muscle cancer	0.000181	0.000655	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—muscle cancer	0.00018	0.00065	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—muscle cancer	0.000177	0.000641	CcSEcCtD
Zolpidem—Nausea—Methotrexate—muscle cancer	0.000172	0.000621	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—muscle cancer	0.000172	0.00062	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—muscle cancer	0.000166	0.000599	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—muscle cancer	0.000159	0.000576	CcSEcCtD
Zolpidem—Rash—Doxorubicin—muscle cancer	0.000158	0.000571	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—muscle cancer	0.000158	0.00057	CcSEcCtD
Zolpidem—Headache—Doxorubicin—muscle cancer	0.000157	0.000567	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—muscle cancer	0.000149	0.000538	CcSEcCtD
